Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
0.900
+0.004 (0.41%)
Mar 9, 2026, 1:24 PM EDT - Market open
Mustang Bio Employees
Mustang Bio had 6 employees as of December 31, 2024. The number of employees decreased by 74 or -92.50% compared to the previous year.
Employees
6
Change (1Y)
-74
Growth (1Y)
-92.50%
Revenue / Employee
n/a
Profits / Employee
-$389,167
Market Cap
6.57M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Aptevo Therapeutics | 37 |
| Theriva Biologics | 22 |
| Processa Pharmaceuticals | 10 |
| XTL Biopharmaceuticals | 10 |
| Purple Biotech | 9 |
| Aprea Therapeutics | 8 |
| Immuron | 7 |
| Can-Fite BioPharma | 5 |
MBIO News
- 8 months ago - Dow Dips 1%; Mustang Bio Shares Spike Higher - Benzinga
- 8 months ago - Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma - GlobeNewsWire
- 1 year ago - Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement - GlobeNewsWire
- 1 year ago - Mustang Bio Announces Sale of Fixed Assets and Exit of Facility - GlobeNewsWire
- 1 year ago - Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 1 year ago - Mustang Bio Announces Closing of $8 Million Public Offering - GlobeNewsWire
- 1 year ago - Mustang Bio Announces Pricing of $8 Million Public Offering - GlobeNewsWire
- 1 year ago - Mustang Bio Announces Reverse Stock Split - GlobeNewsWire